Hydrochloride pioglitazone decreases urinary TGF‐β1 excretion in type 2 diabetics
- 9 June 2010
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 40 (7) , 571-574
Abstract
Eur J Clin Invest 2010; 40 (7): 571–574 Background Thiazolidinediones (TZDs) exert a number of direct reno‐protection beyond its hypoglycaemic effect in type 2 diabetics, which may be partly related to its anti‐fibrosis and anti‐ inflammatory action.Materials and methods A total of 98 type 2 diabetics with fasting blood glucose (FBG) between 7·0 and 13·0 mmol L−1 and glycated haemoglobin A1c (HbA1c) ≥ 7·0% were randomly assigned to add pioglitazone (group DP) or sulfonylurea (group DS) for 12 weeks. FBG, HbA1c, serum creatinine (SCr) and blood urea nitrogen (BUN), and urinary TGF‐β1, albumin (UALB) and creatinine (UCr) were determined at the basal and the 12th week.Results Fasting blood glucose, HbA1c and urinary TGF‐β1/UCr ratio (UTCR) were obviously decreased in both groups after 12 weeks treatment; UALB/UCr ratio (UACR) decreased obviously in group DP (P < 0·01), while slightly in group DS. UACR and UTCR in group DP were significantly lower than those in group DS after treatment, while FBG and HbA1c had no statistical differences between the two groups. In addition, UTCR had positive correlation with UACR (r = 0·367, P < 0·01).Conclusions Pioglitazone decreases urinary TGF‐β1 excretion in type 2 diabetics, which may be partly contributed to its direct reno‐protection.Keywords
This publication has 16 references indexed in Scilit:
- Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitusNephrology Dialysis Transplantation, 2009
- Aldosterone-induced TGF-β1Expression is Regulated by Mitogen-Activated Protein Kinases and Activator Protein-1 in Mesangial CellsJournal of Korean Medical Science, 2009
- Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic ratsNephrology Dialysis Transplantation, 2008
- PPAR-γ agonist protects podocytes from injuryKidney International, 2007
- Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activationAmerican Journal of Physiology-Renal Physiology, 2007
- Beneficial Effects of Thiazolidinediones on Diabetic Nephropathy in OLETF RatsYonsei Medical Journal, 2007
- Thiazolidinediones Ameliorate Diabetic Nephropathy via Cell Cycle–Dependent MechanismsDiabetes, 2006
- Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidneyNephrology, 2005
- Pioglitazone Inhibits Cell Growth and Reduces Matrix Production in Human Kidney FibroblastsJournal of the American Society of Nephrology, 2005
- Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesisKidney International, 1998